← Back
Data updated: Mar 10, 2026
MOVA
OncologyCardiovascularRespiratory
MOVA is a generic drug manufacturer focused on Oncology, Cardiovascular, Respiratory.
1994
Since
1
Drugs
-
Trials
5
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ALBUTEROL SULFATE 2025-12-01
ALBUTEROL SULFATE 2025-11-21
Labeling
ALBUTEROL SULFATE 2025-03-12
ALBUTEROL SULFATE 2024-05-21
ALBUTEROL SULFATE 2024-05-03
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 38%
0 drugs Phase 2: 1 Phase 1: 3
Cardiovascular 31%
0 drugs Phase 2: 2
Respiratory 31%
0 drugs Phase 2: 2
Pipeline Strength Pro
Loading...
Competitors Pro
Novartis big-pharma
Oncology, Cardiovascular, Respiratory
AstraZeneca big-pharma
Oncology, Respiratory, Cardiovascular
Boehringer Ingelheim big-pharma
Oncology, Respiratory, Cardiovascular
GE HEALTHCARE specialty
Cardiovascular, Oncology, Respiratory
BRACCO specialty
Cardiovascular, Oncology, Respiratory
Active (1)
Discontinued (0)
Company Info
- First Approval
- 1994-09-30
- Latest
- 1996-12-10
- Applications
- 1